Drug ID: | NPD5157 |
Drug Name: | Lobeline |
Molecular Formula: | C22H27NO2 |
Canonical SMILES: | O[C@H](c1ccccc1)C[C@@H]1CCC[C@@H](N1C)CC(=O)c1ccccc1 |
Standard InCHI: | InChI=1S/C22H27NO2/c1-23-19(15-21(24)17-9-4-2-5-10-17)13-8-14-20(23)16-22(25)18-11-6-3-7-12-18/h2-7,9-12,19-21,24H,8,13-16H2,1H3/t19-,20+,21-/m0/s1 |
Standard InCHIKey: | MXYUKLILVYORSK-HBMCJLEFSA-N |
Max Developmental Stage: | Phase 1 |
Max Developmental Stage Source: | ChEMBL |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | |
DrugBank | DB05137 |
ChEMBL | CHEMBL122270 |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | D02364 |
PubChem CID | |
ChEBI | 48723 |
CAS Number | 90-69-7 |
Molecular Weight | 337.20 |
ALogP | -1.877 |
MLogP | 3.55 |
XLogP | 6.146 |
HDA | 3 |
HBD | 1 |
Rotatable Bonds | 8 |
TPSA | 40.54 |
RO5 Violation | 1 |